Symbol:
Vipr1
Name:
vasoactive intestinal peptide receptor 1
RGD ID:
11486
MGI Page
MGI
Description:
Predicted to enable G protein-coupled peptide receptor activity; peptide hormone binding activity; and vasoactive intestinal polypeptide receptor activity. Predicted to be involved in adenylate cyclase-activating G protein-coupled receptor signaling pathway. Predicted to be part of receptor complex. Predicted to be active in plasma membrane. Is expressed in brain and cerebral cortex. Human ortholog(s) of this gene implicated in achalasia. Orthologous to human VIPR1 (vasoactive intestinal peptide receptor 1).
Type:
protein-coding
RefSeq Status:
VALIDATED
Previously known as:
AV071699; expressed sequence AV071699; PACAP type II receptor; PACAP-R-2; PACAP-R2; pituitary adenylate cyclase-activating polypeptide type II receptor; vasoactive intestinal polypeptide receptor 1; VI; VIP receptor subtype 1; VIP-R-1; VIP-R1; VP; VPAC1; VPAC1 receptor
RGD Orthologs
Alliance Orthologs
More Info
more info ...
More Info
Species
Gene symbol and name
Data Source
Assertion derived from
less info ...
Orthologs 1
Homo sapiens (human):
VIPR1 (vasoactive intestinal peptide receptor 1)
HGNC
EggNOG, Ensembl, HGNC, HomoloGene, Inparanoid, NCBI, OMA, OrthoDB, OrthoMCL, Panther, PhylomeDB, Treefam
Rattus norvegicus (Norway rat):
Vipr1 (vasoactive intestinal peptide receptor 1)
Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Chinchilla lanigera (long-tailed chinchilla):
Vipr1 (vasoactive intestinal peptide receptor 1)
Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Pan paniscus (bonobo/pygmy chimpanzee):
VIPR1 (vasoactive intestinal peptide receptor 1)
Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Canis lupus familiaris (dog):
VIPR1 (vasoactive intestinal peptide receptor 1)
Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Ictidomys tridecemlineatus (thirteen-lined ground squirrel):
Vipr1 (vasoactive intestinal peptide receptor 1)
Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Sus scrofa (pig):
VIPR1 (vasoactive intestinal peptide receptor 1)
Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Chlorocebus sabaeus (green monkey):
VIPR1 (vasoactive intestinal peptide receptor 1)
Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Heterocephalus glaber (naked mole-rat):
Vipr1 (vasoactive intestinal peptide receptor 1)
Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Alliance orthologs 3
Rattus norvegicus (Norway rat):
Vipr1 (vasoactive intestinal peptide receptor 1)
Alliance
DIOPT (Ensembl Compara|Hieranoid|InParanoid|OMA|OrthoFinder|OrthoInspector|PANTHER|PhylomeDB|SonicParanoid)
Homo sapiens (human):
VIPR1 (vasoactive intestinal peptide receptor 1)
Alliance
DIOPT (Ensembl Compara|HGNC|Hieranoid|InParanoid|OMA|OrthoFinder|OrthoInspector|PANTHER|PhylomeDB|SonicParanoid)
Danio rerio (zebrafish):
vipr1b (vasoactive intestinal peptide receptor 1b)
Alliance
DIOPT (Ensembl Compara|Hieranoid|InParanoid|OMA|OrthoFinder|OrthoInspector|PANTHER|PhylomeDB|SonicParanoid|ZFIN)
Danio rerio (zebrafish):
vipr1a (vasoactive intestinal peptide receptor 1a)
Alliance
DIOPT (Hieranoid|InParanoid|OMA|OrthoFinder|OrthoInspector|PANTHER|PhylomeDB|SonicParanoid|ZFIN)
Caenorhabditis elegans (roundworm):
seb-3
Alliance
DIOPT (Ensembl Compara|InParanoid|PANTHER|SonicParanoid)
Drosophila melanogaster (fruit fly):
Pdfr
Alliance
DIOPT (Ensembl Compara|PANTHER)
Xenopus tropicalis (tropical clawed frog):
vipr1
Alliance
DIOPT (Ensembl Compara|OMA|OrthoFinder|PANTHER)
Latest Assembly:
GRCm39 - Mouse Genome Assembly GRCm39
Position:
Mouse Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCm39 9 121,471,782 - 121,502,020 (+) NCBI GRCm39 GRCm39 mm39 GRCm39 Ensembl 9 121,471,782 - 121,502,020 (+) Ensembl GRCm39 Ensembl GRCm38 9 121,642,716 - 121,672,954 (+) NCBI GRCm38 GRCm38 mm10 GRCm38 GRCm38.p6 Ensembl 9 121,642,716 - 121,672,954 (+) Ensembl GRCm38 mm10 GRCm38 MGSCv37 9 121,551,834 - 121,582,072 (+) NCBI GRCm37 MGSCv37 mm9 NCBIm37 MGSCv36 9 121,491,414 - 121,519,332 (+) NCBI MGSCv36 mm8 Celera 9 122,116,040 - 122,146,512 (+) NCBI Celera Cytogenetic Map 9 F4 NCBI cM Map 9 72.5 NCBI
JBrowse:
View Region in Genome Browser (JBrowse)
Model
Only show annotations with direct experimental evidence (0 objects hidden)
Vipr1 Mouse (1->4)-beta-D-glucan multiple interactions EXP 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of VIPR1 mRNA CTD PMID:36331819 Vipr1 Mouse 1,2,4-trichloro-5-(2,5-dichlorophenyl)benzene multiple interactions EXP 6480464 [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with more ... CTD PMID:25510870 Vipr1 Mouse 1,2-dichloroethane decreases expression EXP 6480464 ethylene dichloride results in decreased expression of VIPR1 mRNA CTD PMID:28960355 Vipr1 Mouse 1,2-dimethylhydrazine multiple interactions EXP 6480464 [1,2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of VIPR1 mRNA CTD PMID:22206623 Vipr1 Mouse 1-naphthyl isothiocyanate decreases expression ISO RGD:3961 6480464 1-Naphthylisothiocyanate results in decreased expression of VIPR1 mRNA CTD PMID:25380136|PMID:30723492 Vipr1 Mouse 17beta-estradiol multiple interactions ISO RGD:735637 6480464 [Estradiol co-treated with Tetrachlorodibenzodioxin] results in increased expression of VIPR1 mRNA CTD PMID:19619570 Vipr1 Mouse 17beta-estradiol decreases expression EXP 6480464 Estradiol results in decreased expression of VIPR1 mRNA CTD PMID:39298647 Vipr1 Mouse 17beta-estradiol increases expression ISO RGD:3961 6480464 Estradiol results in increased expression of VIPR1 mRNA CTD PMID:32145629 Vipr1 Mouse 17beta-estradiol increases expression ISO RGD:735637 6480464 Estradiol results in increased expression of VIPR1 mRNA CTD PMID:19619570 Vipr1 Mouse 2,2',4,4',5,5'-hexachlorobiphenyl multiple interactions EXP 6480464 [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with more ... CTD PMID:25510870 Vipr1 Mouse 2,2',5,5'-tetrachlorobiphenyl multiple interactions EXP 6480464 [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with more ... CTD PMID:25510870 Vipr1 Mouse 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:735637 6480464 [Estradiol co-treated with Tetrachlorodibenzodioxin] results in increased expression of VIPR1 mRNA CTD PMID:19619570 Vipr1 Mouse 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:735637 6480464 Tetrachlorodibenzodioxin results in increased expression of VIPR1 mRNA CTD PMID:12377990|PMID:19619570|PMID:19901195|PMID:20106945|PMID:21632981|PMID:22903824|PMID:30096437 Vipr1 Mouse 2,4,4'-trichlorobiphenyl multiple interactions EXP 6480464 [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with more ... CTD PMID:25510870 Vipr1 Mouse 2,4-dibromophenyl 2,4,5-tribromophenyl ether affects expression EXP 6480464 2,2',4,4',5-brominated diphenyl ether affects the expression of VIPR1 mRNA CTD PMID:38648751 Vipr1 Mouse 3,4-methylenedioxymethamphetamine increases expression EXP 6480464 N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of VIPR1 mRNA CTD PMID:19285098 Vipr1 Mouse 3-methylcholanthrene multiple interactions ISO RGD:735637 6480464 Methylcholanthrene promotes the reaction [AHR protein binds to VIPR1 promoter] CTD PMID:20348232 Vipr1 Mouse 4,4'-diaminodiphenylmethane decreases expression ISO RGD:3961 6480464 4,4'-diaminodiphenylmethane results in decreased expression of VIPR1 mRNA CTD PMID:25380136 Vipr1 Mouse 4-nonylphenol multiple interactions ISO RGD:735637 6480464 [4-tert-octylphenol co-treated with 4-nonylphenol] results in decreased expression of VIPR1 mRNA CTD PMID:23626723 Vipr1 Mouse 4-tert-Octylphenol multiple interactions ISO RGD:735637 6480464 [4-tert-octylphenol co-treated with 4-nonylphenol] results in decreased expression of VIPR1 mRNA CTD PMID:23626723 Vipr1 Mouse 6-propyl-2-thiouracil increases expression ISO RGD:3961 6480464 Propylthiouracil results in increased expression of VIPR1 mRNA CTD PMID:24780913 Vipr1 Mouse 6-propyl-2-thiouracil decreases expression ISO RGD:3961 6480464 Propylthiouracil results in decreased expression of VIPR1 mRNA CTD PMID:30047161 Vipr1 Mouse 8-Br-cAMP decreases expression ISO RGD:735637 6480464 8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of VIPR1 mRNA CTD PMID:22079614 Vipr1 Mouse 9-cis-retinoic acid multiple interactions ISO RGD:735637 6480464 Alitretinoin inhibits the reaction [GW 4064 results in increased expression of VIPR1] CTD PMID:16037943 Vipr1 Mouse acetamide increases expression ISO RGD:3961 6480464 acetamide results in increased expression of VIPR1 mRNA CTD PMID:31881176 Vipr1 Mouse afimoxifene increases expression ISO RGD:735637 6480464 afimoxifene results in increased expression of VIPR1 mRNA CTD PMID:19901195 Vipr1 Mouse aflatoxin B1 increases methylation ISO RGD:735637 6480464 Aflatoxin B1 results in increased methylation of VIPR1 intron CTD PMID:30157460 Vipr1 Mouse Aflatoxin B2 alpha increases methylation ISO RGD:735637 6480464 aflatoxin B2 results in increased methylation of VIPR1 intron CTD PMID:30157460 Vipr1 Mouse all-trans-retinoic acid decreases expression ISO RGD:735637 6480464 Tretinoin results in decreased expression of VIPR1 mRNA CTD PMID:23830798 Vipr1 Mouse all-trans-retinoic acid multiple interactions EXP 6480464 [mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of VIPR1 mRNA CTD PMID:36189433 Vipr1 Mouse amitrole decreases expression ISO RGD:3961 6480464 Amitrole results in decreased expression of VIPR1 mRNA CTD PMID:30047161 Vipr1 Mouse amphetamine decreases expression ISO RGD:3961 6480464 Amphetamine results in decreased expression of VIPR1 mRNA CTD PMID:30779732 Vipr1 Mouse arsane multiple interactions ISO RGD:735637 6480464 [sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of VIPR1 more ... CTD PMID:32525701 Vipr1 Mouse arsenic atom multiple interactions ISO RGD:735637 6480464 [sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of VIPR1 more ... CTD PMID:32525701 Vipr1 Mouse arsenite(3-) increases expression EXP 6480464 arsenite results in increased expression of VIPR1 mRNA CTD PMID:33053406 Vipr1 Mouse arsenite(3-) increases methylation ISO RGD:735637 6480464 arsenite results in increased methylation of VIPR1 promoter CTD PMID:23974009 Vipr1 Mouse Azoxymethane multiple interactions EXP 6480464 [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of VIPR1 more ... CTD PMID:29950665 Vipr1 Mouse benzo[a]pyrene increases methylation ISO RGD:735637 6480464 Benzo(a)pyrene results in increased methylation of VIPR1 promoter CTD PMID:27901495 Vipr1 Mouse benzo[a]pyrene affects methylation ISO RGD:735637 6480464 Benzo(a)pyrene affects the methylation of VIPR1 3' UTR; Benzo(a)pyrene affects the methylation of VIPR1 intron CTD PMID:27901495|PMID:30157460 Vipr1 Mouse Benzo[k]fluoranthene decreases expression EXP 6480464 benzo(k)fluoranthene results in decreased expression of VIPR1 mRNA CTD PMID:26377693 Vipr1 Mouse bisphenol A affects expression ISO RGD:3961 6480464 bisphenol A affects the expression of VIPR1 mRNA CTD PMID:25181051 Vipr1 Mouse bisphenol A increases expression ISO RGD:3961 6480464 bisphenol A results in increased expression of VIPR1 mRNA CTD PMID:32145629|PMID:34947998 Vipr1 Mouse cadmium dichloride decreases expression ISO RGD:735637 6480464 Cadmium Chloride results in decreased expression of VIPR1 mRNA CTD PMID:25596134 Vipr1 Mouse carbon nanotube decreases expression EXP 6480464 Nanotubes, Carbon analog results in decreased expression of VIPR1 mRNA; Nanotubes, Carbon results in decreased more ... CTD PMID:25554681|PMID:25620056 Vipr1 Mouse chenodeoxycholic acid increases expression ISO RGD:735637 6480464 Chenodeoxycholic Acid results in increased expression of VIPR1 mRNA; Chenodeoxycholic Acid results in increased expression more ... CTD PMID:16037943 Vipr1 Mouse chloroacetaldehyde decreases expression ISO RGD:735637 6480464 chloroacetaldehyde results in decreased expression of VIPR1 mRNA CTD PMID:25596134 Vipr1 Mouse chlorpyrifos increases expression ISO RGD:3961 6480464 Chlorpyrifos results in increased expression of VIPR1 mRNA CTD PMID:20682304 Vipr1 Mouse cidofovir anhydrous increases expression ISO RGD:735637 6480464 Cidofovir results in increased expression of VIPR1 mRNA CTD PMID:25596134 Vipr1 Mouse copper(II) sulfate increases expression ISO RGD:735637 6480464 Copper Sulfate results in increased expression of VIPR1 mRNA CTD PMID:19549813 Vipr1 Mouse cyclophosphamide increases expression ISO RGD:3961 6480464 Cyclophosphamide results in increased expression of VIPR1 mRNA CTD PMID:18563302 Vipr1 Mouse dextran sulfate multiple interactions EXP 6480464 [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of VIPR1 more ... CTD PMID:29950665 Vipr1 Mouse Dibutyl phosphate affects expression ISO RGD:735637 6480464 di-n-butylphosphoric acid affects the expression of VIPR1 mRNA CTD PMID:37042841 Vipr1 Mouse dichlorine multiple interactions ISO RGD:3961 6480464 [Ozone co-treated with Chlorine] affects the expression of VIPR1 mRNA CTD PMID:18636392 Vipr1 Mouse dioxygen decreases expression ISO RGD:735637 6480464 Oxygen deficiency results in decreased expression of VIPR1 mRNA CTD PMID:25596134 Vipr1 Mouse elemental selenium increases expression ISO RGD:735637 6480464 Selenium results in increased expression of VIPR1 mRNA CTD PMID:19244175 Vipr1 Mouse flutamide decreases expression ISO RGD:3961 6480464 Flutamide results in decreased expression of VIPR1 mRNA CTD PMID:24136188 Vipr1 Mouse folic acid multiple interactions EXP 6480464 [1,2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of VIPR1 mRNA CTD PMID:22206623 Vipr1 Mouse folic acid decreases expression ISO RGD:735637 6480464 Folic Acid results in decreased expression of VIPR1 mRNA CTD PMID:21867686 Vipr1 Mouse gallic acid increases expression ISO RGD:735637 6480464 Gallic Acid results in increased expression of VIPR1 mRNA CTD PMID:34408198 Vipr1 Mouse glafenine decreases expression ISO RGD:3961 6480464 Glafenine results in decreased expression of VIPR1 mRNA CTD PMID:24136188 Vipr1 Mouse glycidol increases expression ISO RGD:3961 6480464 glycidol results in increased expression of VIPR1 mRNA CTD PMID:24915197 Vipr1 Mouse GW 4064 multiple interactions ISO RGD:735637 6480464 alitretinoin inhibits the reaction [GW 4064 results in increased expression of VIPR1] CTD PMID:16037943 Vipr1 Mouse GW 4064 increases expression ISO RGD:735637 6480464 GW 4064 results in increased expression of VIPR1 CTD PMID:16037943 Vipr1 Mouse lipopolysaccharide multiple interactions ISO RGD:735637 6480464 [S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of VIPR1 mRNA CTD PMID:35811015 Vipr1 Mouse lipopolysaccharide decreases expression ISO RGD:735637 6480464 Lipopolysaccharides results in decreased expression of VIPR1 mRNA CTD PMID:35811015 Vipr1 Mouse methimazole decreases expression ISO RGD:3961 6480464 Methimazole results in decreased expression of VIPR1 mRNA CTD PMID:30047161 Vipr1 Mouse methotrexate affects expression EXP 6480464 Methotrexate affects the expression of VIPR1 mRNA CTD PMID:18502557 Vipr1 Mouse methoxychlor decreases expression ISO RGD:3961 6480464 Methoxychlor results in decreased expression of VIPR1 mRNA CTD PMID:21782745 Vipr1 Mouse mono(2-ethylhexyl) phthalate multiple interactions EXP 6480464 [mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of VIPR1 mRNA CTD PMID:36189433 Vipr1 Mouse Muraglitazar decreases expression ISO RGD:3961 6480464 muraglitazar results in decreased expression of VIPR1 mRNA CTD PMID:21515302 Vipr1 Mouse N-nitrosodiethylamine decreases expression EXP 6480464 Diethylnitrosamine results in decreased expression of VIPR1 mRNA CTD PMID:24535843 Vipr1 Mouse N-nitrosodiethylamine decreases expression ISO RGD:3961 6480464 Diethylnitrosamine results in decreased expression of VIPR1 mRNA CTD PMID:19041683|PMID:19638242 Vipr1 Mouse N-nitrosodimethylamine decreases expression ISO RGD:3961 6480464 Dimethylnitrosamine results in decreased expression of VIPR1 mRNA CTD PMID:25380136 Vipr1 Mouse nebivolol increases expression ISO RGD:735637 6480464 Nebivolol results in increased expression of VIPR1 mRNA CTD PMID:17467819 Vipr1 Mouse nickel atom decreases expression ISO RGD:735637 6480464 Nickel results in decreased expression of VIPR1 mRNA CTD PMID:24768652|PMID:25583101 Vipr1 Mouse nimesulide decreases expression ISO RGD:3961 6480464 nimesulide results in decreased expression of VIPR1 mRNA CTD PMID:24136188 Vipr1 Mouse orphenadrine affects expression ISO RGD:3961 6480464 Orphenadrine affects the expression of VIPR1 mRNA CTD PMID:23665939 Vipr1 Mouse ozone multiple interactions ISO RGD:3961 6480464 [Ozone co-treated with Chlorine] affects the expression of VIPR1 mRNA CTD PMID:18636392 Vipr1 Mouse ozone multiple interactions EXP 6480464 [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased more ... CTD PMID:34911549 Vipr1 Mouse p-tert-Amylphenol multiple interactions ISO RGD:735637 6480464 [4-tert-octylphenol co-treated with 4-nonylphenol] results in decreased expression of VIPR1 mRNA CTD PMID:23626723 Vipr1 Mouse p-toluidine decreases expression ISO RGD:3961 6480464 4-toluidine results in decreased expression of VIPR1 mRNA CTD PMID:27638505 Vipr1 Mouse paracetamol affects expression EXP 6480464 Acetaminophen affects the expression of VIPR1 mRNA CTD PMID:17562736 Vipr1 Mouse PCB138 multiple interactions EXP 6480464 [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with more ... CTD PMID:25510870 Vipr1 Mouse perfluorooctane-1-sulfonic acid multiple interactions EXP 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of VIPR1 mRNA CTD PMID:36331819 Vipr1 Mouse pirinixic acid multiple interactions ISO RGD:735637 6480464 [pirinixic acid binds to and results in increased activity of PPARA protein] which results in more ... CTD PMID:19710929 Vipr1 Mouse pirinixic acid decreases expression EXP 6480464 pirinixic acid results in decreased expression of VIPR1 mRNA CTD PMID:20813756 Vipr1 Mouse propanal increases expression ISO RGD:735637 6480464 propionaldehyde results in increased expression of VIPR1 mRNA CTD PMID:26079696 Vipr1 Mouse quercetin increases expression ISO RGD:735637 6480464 Quercetin results in increased expression of VIPR1 mRNA CTD PMID:15309432 Vipr1 Mouse S-(1,2-dichlorovinyl)-L-cysteine multiple interactions ISO RGD:735637 6480464 [S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of VIPR1 mRNA CTD PMID:35811015 Vipr1 Mouse S-nitrosoglutathione increases expression ISO RGD:735637 6480464 S-Nitrosoglutathione results in increased expression of VIPR1 mRNA CTD PMID:38825487 Vipr1 Mouse selenium atom increases expression ISO RGD:735637 6480464 Selenium results in increased expression of VIPR1 mRNA CTD PMID:19244175 Vipr1 Mouse silicon dioxide increases expression ISO RGD:735637 6480464 Silicon Dioxide analog results in increased expression of VIPR1 mRNA CTD PMID:25895662 Vipr1 Mouse silicon dioxide decreases expression ISO RGD:735637 6480464 Silicon Dioxide results in decreased expression of VIPR1 mRNA CTD PMID:25351596 Vipr1 Mouse silicon dioxide decreases expression EXP 6480464 Silicon Dioxide results in decreased expression of VIPR1 mRNA CTD PMID:23221170 Vipr1 Mouse sodium arsenate multiple interactions ISO RGD:735637 6480464 [sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of VIPR1 more ... CTD PMID:32525701 Vipr1 Mouse sulfadimethoxine decreases expression ISO RGD:3961 6480464 Sulfadimethoxine results in decreased expression of VIPR1 mRNA CTD PMID:30047161 Vipr1 Mouse tetrachloromethane affects expression EXP 6480464 Carbon Tetrachloride affects the expression of VIPR1 mRNA CTD PMID:17484886 Vipr1 Mouse tetrachloromethane decreases expression ISO RGD:3961 6480464 Carbon Tetrachloride results in decreased expression of VIPR1 mRNA CTD PMID:16644059|PMID:31150632 Vipr1 Mouse thioacetamide decreases expression ISO RGD:3961 6480464 Thioacetamide results in decreased expression of VIPR1 mRNA CTD PMID:34492290 Vipr1 Mouse titanium dioxide multiple interactions EXP 6480464 [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of VIPR1 more ... CTD PMID:29950665 Vipr1 Mouse titanium dioxide decreases methylation EXP 6480464 titanium dioxide results in decreased methylation of VIPR1 gene CTD PMID:35295148 Vipr1 Mouse triphenyl phosphate decreases expression ISO RGD:3961 6480464 triphenyl phosphate results in decreased expression of VIPR1 mRNA CTD PMID:30589522 Vipr1 Mouse troglitazone decreases expression ISO RGD:3961 6480464 troglitazone results in decreased expression of VIPR1 mRNA CTD PMID:21515302 Vipr1 Mouse tunicamycin decreases expression EXP 6480464 Tunicamycin results in decreased expression of VIPR1 mRNA CTD PMID:17127020 Vipr1 Mouse valproic acid increases methylation ISO RGD:735637 6480464 Valproic Acid results in increased methylation of VIPR1 gene CTD PMID:29154799 Vipr1 Mouse vinclozolin affects expression ISO RGD:3961 6480464 vinclozolin affects the expression of VIPR1 mRNA CTD PMID:19015723 Vipr1 Mouse zoledronic acid increases expression ISO RGD:735637 6480464 zoledronic acid results in increased expression of VIPR1 mRNA CTD PMID:25596134
(1->4)-beta-D-glucan (EXP) 1,2,4-trichloro-5-(2,5-dichlorophenyl)benzene (EXP) 1,2-dichloroethane (EXP) 1,2-dimethylhydrazine (EXP) 1-naphthyl isothiocyanate (ISO) 17beta-estradiol (EXP,ISO) 2,2',4,4',5,5'-hexachlorobiphenyl (EXP) 2,2',5,5'-tetrachlorobiphenyl (EXP) 2,3,7,8-tetrachlorodibenzodioxine (ISO) 2,4,4'-trichlorobiphenyl (EXP) 2,4-dibromophenyl 2,4,5-tribromophenyl ether (EXP) 3,4-methylenedioxymethamphetamine (EXP) 3-methylcholanthrene (ISO) 4,4'-diaminodiphenylmethane (ISO) 4-nonylphenol (ISO) 4-tert-Octylphenol (ISO) 6-propyl-2-thiouracil (ISO) 8-Br-cAMP (ISO) 9-cis-retinoic acid (ISO) acetamide (ISO) afimoxifene (ISO) aflatoxin B1 (ISO) Aflatoxin B2 alpha (ISO) all-trans-retinoic acid (EXP,ISO) amitrole (ISO) amphetamine (ISO) arsane (ISO) arsenic atom (ISO) arsenite(3-) (EXP,ISO) Azoxymethane (EXP) benzo[a]pyrene (ISO) Benzo[k]fluoranthene (EXP) bisphenol A (ISO) cadmium dichloride (ISO) carbon nanotube (EXP) chenodeoxycholic acid (ISO) chloroacetaldehyde (ISO) chlorpyrifos (ISO) cidofovir anhydrous (ISO) copper(II) sulfate (ISO) cyclophosphamide (ISO) dextran sulfate (EXP) Dibutyl phosphate (ISO) dichlorine (ISO) dioxygen (ISO) elemental selenium (ISO) flutamide (ISO) folic acid (EXP,ISO) gallic acid (ISO) glafenine (ISO) glycidol (ISO) GW 4064 (ISO) lipopolysaccharide (ISO) methimazole (ISO) methotrexate (EXP) methoxychlor (ISO) mono(2-ethylhexyl) phthalate (EXP) Muraglitazar (ISO) N-nitrosodiethylamine (EXP,ISO) N-nitrosodimethylamine (ISO) nebivolol (ISO) nickel atom (ISO) nimesulide (ISO) orphenadrine (ISO) ozone (EXP,ISO) p-tert-Amylphenol (ISO) p-toluidine (ISO) paracetamol (EXP) PCB138 (EXP) perfluorooctane-1-sulfonic acid (EXP) pirinixic acid (EXP,ISO) propanal (ISO) quercetin (ISO) S-(1,2-dichlorovinyl)-L-cysteine (ISO) S-nitrosoglutathione (ISO) selenium atom (ISO) silicon dioxide (EXP,ISO) sodium arsenate (ISO) sulfadimethoxine (ISO) tetrachloromethane (EXP,ISO) thioacetamide (ISO) titanium dioxide (EXP) triphenyl phosphate (ISO) troglitazone (ISO) tunicamycin (EXP) valproic acid (ISO) vinclozolin (ISO) zoledronic acid (ISO)
1.
Electronic Transfer of Homolog Data
MGD and Homologene mouse data transfer
2.
MGDs mouse GO annotations
MGD data from the GO Consortium
3.
Pituitary adenylate cyclase-activating polypeptide and sonic hedgehog interact to control cerebellar granule precursor cell proliferation.
Nicot A, etal., J Neurosci 2002 Nov 1;22(21):9244-54.
4.
Analysis of the mouse transcriptome based on functional annotation of 60,770 full-length cDNAs.
Okazaki Y, etal., Nature. 2002 Dec 5;420(6915):563-73.
5.
Age-dependent association of idiopathic achalasia with vasoactive intestinal peptide receptor 1 gene.
Paladini F, etal., Neurogastroenterol Motil. 2009 Jun;21(6):597-602. Epub 2009 Feb 27.
6.
Mouse MP Annotation Import Pipeline
RGD automated import pipeline
7.
ClinVar Automated Import and Annotation Pipeline
RGD automated import pipeline for ClinVar variants, variant-to-disease annotations and gene-to-disease annotations
8.
Data Import for Chemical-Gene Interactions
RGD automated import pipeline for gene-chemical interactions
9.
Anti-hyperglycemic, antioxidant and anti-inflammatory effects of VIP and a VPAC1 agonist on streptozotocin-induced diabetic mice.
Yu R, etal., Peptides. 2011 Feb;32(2):216-22. Epub 2010 Dec 1.
10.
Differential expression of vasoactive intestinal peptide receptor 1 expression in inflammatory bowel disease.
Yukawa T, etal., Int J Mol Med. 2007 Aug;20(2):161-7.
Vipr1 (Mus musculus - house mouse)
Mouse Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCm39 9 121,471,782 - 121,502,020 (+) NCBI GRCm39 GRCm39 mm39 GRCm39 Ensembl 9 121,471,782 - 121,502,020 (+) Ensembl GRCm39 Ensembl GRCm38 9 121,642,716 - 121,672,954 (+) NCBI GRCm38 GRCm38 mm10 GRCm38 GRCm38.p6 Ensembl 9 121,642,716 - 121,672,954 (+) Ensembl GRCm38 mm10 GRCm38 MGSCv37 9 121,551,834 - 121,582,072 (+) NCBI GRCm37 MGSCv37 mm9 NCBIm37 MGSCv36 9 121,491,414 - 121,519,332 (+) NCBI MGSCv36 mm8 Celera 9 122,116,040 - 122,146,512 (+) NCBI Celera Cytogenetic Map 9 F4 NCBI cM Map 9 72.5 NCBI
VIPR1 (Homo sapiens - human)
Human Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCh38 3 42,489,299 - 42,537,568 (+) NCBI GRCh38 GRCh38 hg38 GRCh38 GRCh38.p14 Ensembl 3 42,489,299 - 42,537,573 (+) Ensembl GRCh38 hg38 GRCh38 GRCh37 3 42,530,791 - 42,579,060 (+) NCBI GRCh37 GRCh37 hg19 GRCh37 Build 36 3 42,519,121 - 42,554,064 (+) NCBI NCBI36 Build 36 hg18 NCBI36 Build 34 3 42,519,120 - 42,554,064 NCBI Celera 3 42,484,508 - 42,519,469 (+) NCBI Celera Cytogenetic Map 3 p22.1 NCBI HuRef 3 42,574,992 - 42,623,180 (+) NCBI HuRef CHM1_1 3 42,481,967 - 42,530,261 (+) NCBI CHM1_1 T2T-CHM13v2.0 3 42,507,314 - 42,555,561 (+) NCBI T2T-CHM13v2.0
Vipr1 (Rattus norvegicus - Norway rat)
Rat Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCr8 8 130,181,219 - 130,217,098 (+) NCBI GRCr8 mRatBN7.2 8 121,303,739 - 121,339,587 (+) NCBI mRatBN7.2 mRatBN7.2 mRatBN7.2 Ensembl 8 121,310,248 - 121,339,585 (+) Ensembl mRatBN7.2 Ensembl UTH_Rnor_SHR_Utx 8 126,909,204 - 126,938,516 (+) NCBI Rnor_SHR UTH_Rnor_SHR_Utx UTH_Rnor_SHRSP_BbbUtx_1.0 8 125,108,275 - 125,137,587 (+) NCBI Rnor_SHRSP UTH_Rnor_SHRSP_BbbUtx_1.0 UTH_Rnor_WKY_Bbb_1.0 8 122,937,779 - 122,967,104 (+) NCBI Rnor_WKY UTH_Rnor_WKY_Bbb_1.0 Rnor_6.0 8 130,283,453 - 130,313,431 (+) NCBI Rnor6.0 Rnor_6.0 rn6 Rnor6.0 Rnor_5.0 8 129,467,937 - 129,496,866 (+) NCBI Rnor5.0 Rnor_5.0 rn5 Rnor5.0 Celera 8 120,444,918 - 120,474,479 (+) NCBI Celera Cytogenetic Map 8 q32 NCBI
Vipr1 (Chinchilla lanigera - long-tailed chinchilla)
Chinchilla Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl ChiLan1.0 Ensembl NW_004955420 28,234,153 - 28,253,168 (-) Ensembl ChiLan1.0 ChiLan1.0 NW_004955420 28,234,590 - 28,253,146 (-) NCBI ChiLan1.0 ChiLan1.0
VIPR1 (Pan paniscus - bonobo/pygmy chimpanzee)
Bonobo Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl NHGRI_mPanPan1-v2 2 42,464,670 - 42,503,777 (+) NCBI NHGRI_mPanPan1-v2 NHGRI_mPanPan1 3 42,469,438 - 42,504,483 (+) NCBI NHGRI_mPanPan1 Mhudiblu_PPA_v0 3 42,407,591 - 42,442,565 (+) NCBI Mhudiblu_PPA_v0 Mhudiblu_PPA_v0 panPan3 PanPan1.1 3 42,669,338 - 42,705,170 (+) NCBI panpan1.1 PanPan1.1 panPan2 PanPan1.1 Ensembl 3 42,670,195 - 42,705,170 (+) Ensembl panpan1.1 panPan2
VIPR1 (Canis lupus familiaris - dog)
Dog Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl CanFam3.1 23 11,635,809 - 11,666,926 (+) NCBI CanFam3.1 CanFam3.1 canFam3 CanFam3.1 CanFam3.1 Ensembl 23 11,635,394 - 11,666,936 (+) Ensembl CanFam3.1 canFam3 CanFam3.1 Dog10K_Boxer_Tasha 23 11,609,898 - 11,641,322 (+) NCBI Dog10K_Boxer_Tasha ROS_Cfam_1.0 23 11,924,939 - 11,956,370 (+) NCBI ROS_Cfam_1.0 ROS_Cfam_1.0 Ensembl 23 11,924,529 - 11,957,534 (+) Ensembl ROS_Cfam_1.0 Ensembl UMICH_Zoey_3.1 23 11,726,543 - 11,757,961 (+) NCBI UMICH_Zoey_3.1 UNSW_CanFamBas_1.0 23 11,868,801 - 11,900,208 (+) NCBI UNSW_CanFamBas_1.0 UU_Cfam_GSD_1.0 23 11,873,062 - 11,904,503 (+) NCBI UU_Cfam_GSD_1.0
Vipr1 (Ictidomys tridecemlineatus - thirteen-lined ground squirrel)
Squirrel Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl HiC_Itri_2 NW_024405118 200,208,554 - 200,255,619 (-) NCBI HiC_Itri_2 SpeTri2.0 Ensembl NW_004936695 2,564,890 - 2,607,676 (-) Ensembl SpeTri2.0 SpeTri2.0 Ensembl SpeTri2.0 NW_004936695 2,564,917 - 2,597,009 (-) NCBI SpeTri2.0 SpeTri2.0 SpeTri2.0
VIPR1 (Sus scrofa - pig)
Pig Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl Sscrofa11.1 Ensembl 13 26,036,629 - 26,075,691 (+) Ensembl Sscrofa11.1 susScr11 Sscrofa11.1 Sscrofa11.1 13 26,036,610 - 26,073,168 (+) NCBI Sscrofa11.1 Sscrofa11.1 susScr11 Sscrofa11.1 Sscrofa10.2 13 28,704,211 - 28,740,358 (+) NCBI Sscrofa10.2 Sscrofa10.2 susScr3
VIPR1 (Chlorocebus sabaeus - green monkey)
Green Monkey Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl ChlSab1.1 22 3,950,129 - 3,984,849 (+) NCBI ChlSab1.1 ChlSab1.1 chlSab2 ChlSab1.1 Ensembl 22 3,950,193 - 3,984,948 (+) Ensembl ChlSab1.1 ChlSab1.1 Ensembl chlSab2 Vero_WHO_p1.0 NW_023666041 163,214,473 - 163,249,573 (-) NCBI Vero_WHO_p1.0 Vero_WHO_p1.0
Vipr1 (Heterocephalus glaber - naked mole-rat)
.
Predicted Target Of
Count of predictions: 2175 Count of miRNA genes: 768 Interacting mature miRNAs: 1030 Transcripts: ENSMUST00000035115, ENSMUST00000129394, ENSMUST00000139189, ENSMUST00000149959 Prediction methods: Miranda, Rnahybrid, Targetscan Result types: miRGate_prediction
18182932 Metl3_m metabolite locus 3, N-acetylglutamate (mouse) 9 89440541 123440541 Mouse 1301649 Psl1_m promotion susceptibility QTL 1 (mouse) Not determined 9 89289476 123289595 Mouse 1357648 Obq18_m obesity QTL 18 (mouse) Not determined 9 101829255 124359700 Mouse 12904961 Gmmq7_m gastrocnemius muscle mass QTL 7 (mouse) 9 91560372 124359700 Mouse 10412242 Alpq8_m alcohol preference QTL 8 (mouse) Not determined 9 89162124 123162124 Mouse 1301789 Pbwg4_m postnatal body weight growth 4 (mouse) Not determined 9 103118511 124359700 Mouse 14746992 Manh67_m mandible shape 67 (mouse) 9 93865836 124359700 Mouse 10412290 Pvacm1l_m plasma vascular cell adhesion molecule 1 levels (mouse) Not determined 9 103118511 124359700 Mouse 12879896 Berr3_m berghei resistance locus 3 (mouse) 9 103118511 124359700 Mouse 12880422 V25Dq6_m vitamin D inactive form serum level QTL 6 (mouse) 9 87677199 121677199 Mouse 1302001 Bdln5_m body length 5 (mouse) Not determined 9 93591658 124359700 Mouse 1301297 Lcho1_m liver cholesterol 1 (mouse) Not determined 9 100889929 124359700 Mouse 11537364 Cnes5_m C. neoformans susceptibility locus 5 (mouse) 9 96746658 124359700 Mouse 12904937 Edlmmq9_m extensor digitorum longus muscle mass QTL 9 (mouse) 9 91560372 124359700 Mouse 1357627 Tgq2_m triglyceride QTL 2 (mouse) Not determined 9 101829255 124359700 Mouse 12910773 Splic3_m spleen iron content 3 (mouse) 9 91291078 124359700 Mouse 12910772 Lvic6_m liver iron content 6 (mouse) 9 91291078 124359700 Mouse 13463480 Mchcq2_m mean corpuscular hemoglobin concentration QTL 2 (mouse) 9 91518283 124359700 Mouse 12910770 Splic1_m spleen iron content 1 (mouse) 9 91291078 124359700 Mouse 12904947 Tammq7_m tibialis anterior muscle mass QTL 7 (mouse) 9 91560372 124359700 Mouse 1558767 Skmw11_m skeletal muscle weight 11 (mouse) Not determined 9 91518283 124359700 Mouse 13463477 Rbc9_m red blood cell count 9 (mouse) 9 91518283 124359700 Mouse 13463478 Mchq18_m mean corpuscular hemoglobin QTL 18 (mouse) 9 91518283 124359700 Mouse 13463475 Hctq7_m hematocrit QTL 7 (mouse) 9 91518283 124359700 Mouse 13463474 Hbbcq5_m hemoglobin concentration QTL 5 (mouse) 9 91518283 124359700 Mouse 1301484 Bwq6_m body weight (mouse) Not determined 9 93591658 124359700 Mouse
AV071699
Mouse Assembly Chr Position (strand) Source JBrowse GRCm38 9 121,672,787 - 121,672,875 UniSTS GRCm38 MGSCv37 9 121,581,905 - 121,581,993 UniSTS GRCm37 Celera 9 122,146,345 - 122,146,433 UniSTS Cytogenetic Map 9 F4 UniSTS cM Map 9 72.5 UniSTS Whitehead/MRC_RH 9 1226.11 UniSTS
Vipr1
Mouse Assembly Chr Position (strand) Source JBrowse Cytogenetic Map 9 F4 UniSTS cM Map 9 72.5 UniSTS
Vipr1
Mouse Assembly Chr Position (strand) Source JBrowse Cytogenetic Map 9 F4 UniSTS
Click on a value in the shaded box below the category label to view a detailed expression data table for that system.
Ensembl Acc Id:
ENSMUST00000035115 ⟹ ENSMUSP00000035115
Type:
CODING
Position:
Mouse Assembly Chr Position (strand) Source GRCm39 Ensembl 9 121,471,782 - 121,502,020 (+) Ensembl GRCm38.p6 Ensembl 9 121,642,716 - 121,672,954 (+) Ensembl
Ensembl Acc Id:
ENSMUST00000129394
Type:
CODING
Position:
Mouse Assembly Chr Position (strand) Source GRCm39 Ensembl 9 121,493,681 - 121,494,973 (+) Ensembl GRCm38.p6 Ensembl 9 121,664,615 - 121,665,907 (+) Ensembl
Ensembl Acc Id:
ENSMUST00000139189
Type:
CODING
Position:
Mouse Assembly Chr Position (strand) Source GRCm39 Ensembl 9 121,472,117 - 121,489,291 (+) Ensembl GRCm38.p6 Ensembl 9 121,643,051 - 121,660,225 (+) Ensembl
Ensembl Acc Id:
ENSMUST00000149959
Type:
CODING
Position:
Mouse Assembly Chr Position (strand) Source GRCm39 Ensembl 9 121,497,779 - 121,498,575 (+) Ensembl GRCm38.p6 Ensembl 9 121,668,713 - 121,669,509 (+) Ensembl
Ensembl Acc Id:
ENSMUST00000213272
Type:
CODING
Position:
Mouse Assembly Chr Position (strand) Source GRCm39 Ensembl 9 121,471,827 - 121,486,669 (+) Ensembl GRCm38.p6 Ensembl 9 121,642,761 - 121,657,603 (+) Ensembl
RefSeq Acc Id:
NM_011703 ⟹ NP_035833
RefSeq Status:
VALIDATED
Type:
CODING
Position:
Mouse Assembly Chr Position (strand) Source GRCm39 9 121,471,782 - 121,502,020 (+) NCBI GRCm38 9 121,642,716 - 121,672,954 (+) ENTREZGENE MGSCv37 9 121,551,834 - 121,582,072 (+) RGD Celera 9 122,116,040 - 122,146,512 (+) RGD cM Map 9 ENTREZGENE
Sequence:
CCCGCCGCCCTCCCCTAGCCTGGAGCTGTGCCTCATAGCGCCCGGGCCGCTGGCCCGCGCCACTCTCCCGCGCTGCGTTAGCCACAGACCCCGTAGGCGCTCTCGGCTGCCTGCCGCGGGCTCAGGGC GGACCATGCGCCCTCCGAGCCTACCGCCTGCCCGCTGGCTCTGCGTGCTGGCAGGAGCCCTCGCCTGCGCCCTCGGACCCGCGGGCAGCCGGGCAGCCAGCCCACACCAGGAGTGTGAGTACCTGCAG ATGATTGAGAAACAGCGTCAGCAGTGCCTGGAGGAGGCCCAGCTGGAGAATGAAACCACAGGCTGCAGCAAGATGTGGGACAACCTCACCTGCTGGCCAACGACCCCTTGGGGCCAGGTGGTAGTCCT GGACTGCCCCCTCATCTTTCAACTGTTTTCCCCCATTCACGGCTATAACATCAGCCGTAACTGCACTGAAGAAGGCTGGTCACAACTGGAACCTGGCCCCTACCACATTGCCTGCGGCCTGAATGACA GGGCATCTAGTATGGATGAGCAGCAACAGACTGAGTTCTACGATGCAGTGAAGACCGGCTACACCATCGGCTACAGCTTGTCCCTTGCCAGCCTCCTGGTTGCCATGGCTATCTTGAGCCTGTTCAGG AAGCTGCACTGTACTCGAAACTACATCCACATGCATCTCTTCATGTCCTTCATCCTGAGGGCCACCGCCGTCTTCATCAAGGATATGGCCCTCTTCAACAACGGGGAGACAGACCACTGCTCTGAGGC CTCGGTGAGCTGCAAGGCAGCAGTGGTTTTCTTCCAGTATTGCGTCATGGCCAACTTCTTCTGGCTGCTGGTCGAGGGCCTCTACCTACACACCCTGCTGGCCGTCTCCTTCTTCTCTGAGCGGAAGT ACTTCTGGGGGTACATACTCATCGGCTGGGGAGTGCCCAGTGTGTTCATCATGATATGGACGATTGTCAGGATCCATTTTGAGGATTTCGGGTGCTGGGACACCATCATCAACTCCTCACTGTGGTGG ATCATAAAGGGCCCCATCCTCATCTCCATCTTGGTGAACTTCATCCTGTTTATCTGCATCATCCGAATCCTGGTTCAGAAGCTACGGCCACCCGACATTGGGAAGAATGATAGCAGCCCATACTCGAG GCTGGCCAAGTCCACACTTCTGCTCATCCCTCTGTTTGGAGTTCACTATGTCATGTTTGCCTTCTTCCCCGACAACTTTAAGGCCCAGGTGAAAATGGTCTTTGAACTCGTCGTAGGGTCTTTCCAGG GTTTTGTGGTGGCCATCCTCTACTGCTTCCTCAATGGCGAGGTGCAGGCAGAGCTGCGACGGAAGTGGCGGCGTTGGCATCTGCAGGGCGTCCTGGGCTGGAGCTCCAAATCACAACACCCGTGGGGA GGCAGCAACGGCGTCTCGTGCAGCACACAGGTGTCCATGCTGACCCGCGTCAGCCCGAGCGCGCGCCGCTCCTCCAGCTTCCAAGCGGAGGTCTCCCTGGTCTGACCGCCAGAGGCCGCCAGGCCCCT TCGCACCCTCCCCACGCCAGCCCCTGGAGCAGAGGTCTGCAGCGACGCCGCTGGCTCCAGCCTTTTGTAGGGACACAATCCTTTGCTGCAGCCAGGACCCGGTCCATGCTAGCTGGAGAGCTGGGAGG TCTAACCCTGGAGGATGCAAGGAGGAACCAGCATCGGACTCCACCACCCAAGGCTGCTCTGCCAGTCATGCGCACAACATCTGCATTCACCTCCTGGAAAGCAAACCGCCTGCCCTCAAAGCTTTGGA ACTCTGAGGGCAAAAGGTTCCGCCCCGTCGGTGCCTAGAATTCCACTGGGGCGCTCAAGTCGCTTTGGGTTAAGCGTTGCCATTGAGACTCCTCTCTGAGGATGCAGCCCCCTCCCTCCGTTTATCTG CCAGCTCTTCCGGGTGGGTGAGTTCTTCTACCTCAGGCAGATATGGTTGTGACCTGGAGTTTCAGTTTGGGGATCACAGCTGTGTTGCGGTCCTCCCTCAGGATGGAATTGCCCCAGTGAATCGTCAG ACCTGGGAGCTCAGGGACCTATCTCTGGGGAGGAGGGGTGGGGAGAAGGCAGCCCTGCCCGTGCTCACCAAGTGACTTTGTCCATCAAGTAGGACCAGTCCACTAGCCTTATGTACAACCAAAGCAAT AGCGAGCTGCCGCCTCTGGGCGCTTATCTACACACCAACCACTGCTGCAAGGGTCAGAGGCATGAGCACACAGGCCCCTTGATCCTGGGCCACCCTGATATCACTGGTAGTGATACTGAGTCCTGTGA GAGCAGGTATCCTTTCCTGTTGCTAAAGACTACCTTTTTTACATATTGTGGTCTGCTGGATTCTCTGGGGGTCGCATTACCATAGATGCTATTGCCACCCTCAGTCTCCAGTTCCTGTGGAGAGTGAT TATGTCTGACATAAAAGCCTGGGGAGGGGGCAAGGCATCTTATGCCTCCCTCCATCTTTATAGCGATAATGGCTTCTAATCCAAACTGGTGTCAGCGGGCTCTTCTCAGAGCTGCACCAGGCTTGTAT GACAATAAACATTGGCTCTAGCAGGCTTGGTTCCCCTAGCCACTGTGGGTCTCCTGCTTCTTCTAAGCAGCTGTGTCACCTCTGCTCTAGTGAGAGATGACCCTTCTGGCTTTGGGCAGGAGCCCCAC ACAAGAGCCTTTGATTCACATGTAAATGTGAAGAGGTTGTGACAGGGGTCCGTTGTGACCCTCCCTCCCCTAAACCCATCTGGGAGGAGACAGATTCTGCCTCAGACCAAATCAAAACAGCCAACAGA GCTGTCACAGCCAGCAAGGGTTCGACATCATTCCTGAAAACACAGCAAACAGGAAATGCAGCAACCAGGTCGCTGCTGCCTAGGAGCCAACCAAGAGGGCTCAATAATGGAGATTCCCCAGCACAAGT GAGAAGAGGCCAGTCTGGCTAATGGAAAGGAGTAGACAGAGCAGTGGGGCAAAGCAGGTGACATTGGTTGGTCAGTGAGAGACAGCTAGCTCCCAAGGGTTTGTGCAAACACACTTGTGTAAACTTGT GGGTGTCAGGCTGGTGTAAAGAAGCCAGCATGGGCTAGCAGAGGTTCAAACCTGCCTGCCATACCCCATTCAAAGGCTGCTGCACCCAGTACCAACCCCCTGCCTAAATGAATGGGACCAAGATTTCC CCAGCAGTGCTGTGTTGTGGCACCAGCGTAAGGCGCAGGGCCCTGGGAGAGCAGCAGTTACCAGCCAAGAGGACAAAGTGAGTAAAACTCAAAGTGTGTTCAAGAGAGGACGAGCAGAGTTAGGAGGT GAGAGGCTAATTGGAGGGCATTTCGGAATAAAGAGAGACTTGGGAGGCTTGGGTGAGGAGCTAAGAAAACTTGTGCTGGCATCCTAGGTTAGTGACAGCCCTGGGACTTCCAGGACACCCAGGACCTT TTGGCAGGCGAACTCATCTCTATCGCCATCTAGTGGGCACTTCAAAGACTTGACCAACTTTGGCCACCTTAGGGCTTCCTATTGTCAAGTAGGTCTCACCCTGGGAGACAACCAACAACGAAAGCATG GCTCCATTACTGAGCTCCCAAGAGTGGTGTGTGGACCATACGTAAGGCTTGCCCCACACCTCGCCCTCAGGCCAAACCACTGGCCCCTTGTGAGTCTTGCCTTGACCCAAAAGGACCTGATGGAACCC AGCCCCTGGTGGCTCCTTAAAACTGAACCCTACCCACAATCTCCAAGGACAAAGGCTAGTTAGCTGAAGCGGGTATGGACAGGGATCCGTAAATCTGAGTCCAGAGAAGGTTCGTTCTGTGGGAAAGG CTTGTTCACAGGCAGTCCTCCCACTCAGGACACAGCCTGTCGGAAGAGACTGGATTACCGGCTAGCAGAACAGCACTGAGGTGTTTGAGGGCTGGGAGTGGTCCTAGAATCCCAAGGGAATGTGTTGG GTGTCAGGGACACCCAAGTTTGGGGGGCACTTGCCAGTAGAGACAAAGAGAAGGTCTATCCTTCCGATGAGGCTGAGAGATGGGGAGTGGTTAGTTAACACAGAGAAGGACCCAGGTCTGGAAAGGGT GCCAGGCCATCCACAGGAAAGAGAGGAGGTGAGACAATGGCCTGGTTTGGGACCAGGTGCTGAATGTTGTGTCTGCAGGGTATCTGAGAAGAGCCCCTCTAAGGCGGTTAGAAATTACAACCTAAAGG GACAGAGGGCAGGAAGACCAAAGCAGTCCCTTTGGAAGGAACAGTGAGTGTCCGGGCAAGTCCCCAGGCACCCCATGGGGTGTGCTGGGCACAGTCTGGAGAGGAGACTGACTCAGCCCCTCCATCCT AGCTGCCACACAGGGTCTGTTTTAATGAGCAGTGGCCAGCTTCCCTACCCCCATGTGGGAACAAGAACAGCTCTTATCTCTCTGGGGGAAGGGGAAGGGGCGGGACCACAGCTGGCAGTCATTAAACA CCCTGCTCTAGGCAGGGATGGCCAAGATATTAATAGCTTCGGGAGTCTATGGCCCCAAAGACTTGGCCTCCCAGGAAAAGGACAGAGCAACCGCAGCAGGCCAGAGGGATGCGTCAGGAGGCCATCTT GGCAATGCCCCAGCCTCCACACAAGGCAAATGGGATAACCAGAAAATAGAGAAGGAAAAGTCATTGTAGAGGCAGATGCTGAACCCAGCTTTCCAGAACCCCTGGTCGTGCCTCAGATATTCTATATC TTGTCAAAGATGGGGTCATTTGGCTGTGCCCTACCTGGAAACACAAAAAGAGTCGATCCAGTTAGCAGTCCTGATTCCGTCTTGACATATTGTTTATCCTGTATTTTTGCATTAATTTTGATATTTTA AAATACTGCATTAAAATATTATTTACCTTGAGTCCTGAAAAAAAAAAAAAAAAAAAAAAAAAAAA
hide sequence
RefSeq Acc Id:
XM_006512068 ⟹ XP_006512131
Type:
CODING
Position:
Mouse Assembly Chr Position (strand) Source GRCm39 9 121,471,795 - 121,502,013 (+) NCBI GRCm38 9 121,642,729 - 121,672,947 (+) NCBI
Sequence:
CCTAGCCTGGAGCTGTGCCTCATAGCGCCCGGGCCGCTGGCCCGCGCCACTCTCCCGCGCTGCGTTAGCCACAGACCCCGTAGGCGCTCTCGGCTGCCTGCCGCGGGCTCAGGGCGGACCATGCGCCC TCCGAGCCTACCGCCTGCCCGCTGGCTCTGCGTGCTGGCAGGAGCCCTCGCCTGCGCCCTCGGACCCGCGGGCAGCCGGGCAGCCAGCCCACACCAGGAGTGTGAGTACCTGCAGATGATTGAGAAAC AGCGTCAGCAGTGCCTGGAGGAGGCCCAGCTGGAGAATGAAACCACAGGCTGCAGCAAGATGTGGGACAACCTCACCTGCTGGCCAACGACCCCTTGGGGCCAGGTGGTAGTCCTGGACTGCCCCCTC ATCTTTCAACTGTTTTCCCCCATTCACGGCTATAACATCAGCCGTAACTGCACTGAAGAAGGCTGGTCACAACTGGAACCTGGCCCCTACCACATTGCCTGCGGCCTGAATGACAGGGCATCTAGTAT GGATGAGCAACAGACTGAGTTCTACGATGCAGTGAAGACCGGCTACACCATCGGCTACAGCTTGTCCCTTGCCAGCCTCCTGGTTGCCATGGCTATCTTGAGCCTGTTCAGGAAGCTGCACTGTACTC GAAACTACATCCACATGCATCTCTTCATGTCCTTCATCCTGAGGGCCACCGCCGTCTTCATCAAGGATATGGCCCTCTTCAACAACGGGGAGACAGACCACTGCTCTGAGGCCTCGGTGAGCTGCAAG GCAGCAGTGGTTTTCTTCCAGTATTGCGTCATGGCCAACTTCTTCTGGCTGCTGGTCGAGGGCCTCTACCTACACACCCTGCTGGCCGTCTCCTTCTTCTCTGAGCGGAAGTACTTCTGGGGGTACAT ACTCATCGGCTGGGGAGTGCCCAGTGTGTTCATCATGATATGGACGATTGTCAGGATCCATTTTGAGGATTTCGGGTGCTGGGACACCATCATCAACTCCTCACTGTGGTGGATCATAAAGGGCCCCA TCCTCATCTCCATCTTGGTGAACTTCATCCTGTTTATCTGCATCATCCGAATCCTGGTTCAGAAGCTACGGCCACCCGACATTGGGAAGAATGATAGCAGCCCATACTCGAGGCTGGCCAAGTCCACA CTTCTGCTCATCCCTCTGTTTGGAGTTCACTATGTCATGTTTGCCTTCTTCCCCGACAACTTTAAGGCCCAGGTGAAAATGGTCTTTGAACTCGTCGTAGGGTCTTTCCAGGGTTTTGTGGTGGCCAT CCTCTACTGCTTCCTCAATGGCGAGGTGCAGGCAGAGCTGCGACGGAAGTGGCGGCGTTGGCATCTGCAGGGCGTCCTGGGCTGGAGCTCCAAATCACAACACCCGTGGGGAGGCAGCAACGGCGTCT CGTGCAGCACACAGGTGTCCATGCTGACCCGCGTCAGCCCGAGCGCGCGCCGCTCCTCCAGCTTCCAAGCGGAGGTCTCCCTGGTCTGACCGCCAGAGGCCGCCAGGCCCCTTCGCACCCTCCCCACG CCAGCCCCTGGAGCAGAGGTCTGCAGCGACGCCGCTGGCTCCAGCCTTTTGTAGGGACACAATCCTTTGCTGCAGCCAGGACCCGGTCCATGCTAGCTGGAGAGCTGGGAGGTCTAACCCTGGAGGAT GCAAGGAGGAACCAGCATCGGACTCCACCACCCAAGGCTGCTCTGCCAGTCATGCGCACAACATCTGCATTCACCTCCTGGAAAGCAAACCGCCTGCCCTCAAAGCTTTGGAACTCTGAGGGCAAAAG GTTCCGCCCCGTCGGTGCCTAGAATTCCACTGGGGCGCTCAAGTCGCTTTGGGTTAAGCGTTGCCATTGAGACTCCTCTCTGAGGATGCAGCCCCCTCCCTCCGTTTATCTGCCAGCTCTTCCGGGTG GGTGAGTTCTTCTACCTCAGGCAGATATGGTTGTGACCTGGAGTTTCAGTTTGGGGATCACAGCTGTGTTGCGGTCCTCCCTCAGGATGGAATTGCCCCAGTGAATCGTCAGACCTGGGAGCTCAGGG ACCTATCTCTGGGGAGGAGGGGTGGGGAGAAGGCAGCCCTGCCCGTGCTCACCAAGTGACTTTGTCCATCAAGTAGGACCAGTCCACTAGCCTTATGTACAACCAAAGCAATAGCGAGCTGCCGCCTC TGGGCGCTTATCTACACACCAACCACTGCTGCAAGGGTCAGAGGCATGAGCACACAGGCCCCTTGATCCTGGGCCACCCTGATATCACTGGTAGTGATACTGAGTCCTGTGAGAGCAGGTATCCTTTC CTGTTGCTAAAGACTACCTTTTTTACATATTGTGGTCTGCTGGATTCTCTGGGGGTCGCATTACCATAGATGCTATTGCCACCCTCAGTCTCCAGTTCCTGTGGAGAGTGATTATGTCTGACATAAAA GCCTGGGGAGGGGGCAAGGCATCTTATGCCTCCCTCCATCTTTATAGCGATAATGGCTTCTAATCCAAACTGGTGTCAGCGGGCTCTTCTCAGAGCTGCACCAGGCTTGTATGACAATAAACATTGGC TCTAGCAGGCTTGGTTCCCCTAGCCACTGTGGGTCTCCTGCTTCTTCTAAGCAGCTGTGTCACCTCTGCTCTAGTGAGAGATGACCCTTCTGGCTTTGGGCAGGAGCCCCACACAAGAGCCTTTGATT CACATGTAAATGTGAAGAGGTTGTGACAGGGGTCCGTTGTGACCCTCCCTCCCCTAAACCCATCTGGGAGGAGACAGATTCTGCCTCAGACCAAATCAAAACAGCCAACAGAGCTGTCACAGCCAGCA AGGGTTCGACATCATTCCTGAAAACACAGCAAACAGGAAATGCAGCAACCAGGTCGCTGCTGCCTAGGAGCCAACCAAGAGGGCTCAATAATGGAGATTCCCCAGCACAAGTGAGAAGAGGCCAGTCT GGCTAATGGAAAGGAGTAGACAGAGCAGTGGGGCAAAGCAGGTGACATTGGTTGGTCAGTGAGAGACAGCTAGCTCCCAAGGGTTTGTGCAAACACACTTGTGTAAACTTGTGGGTGTCAGGCTGGTG TAAAGAAGCCAGCATGGGCTAGCAGAGGTTCAAACCTGCCTGCCATACCCCATTCAAAGGCTGCTGCACCCAGTACCAACCCCCTGCCTAAATGAATGGGACCAAGATTTCCCCAGCAGTGCTGTGTT GTGGCACCAGCGTAAGGCGCAGGGCCCTGGGAGAGCAGCAGTTACCAGCCAAGAGGACAAAGTGAGTAAAACTCAAAGTGTGTTCAAGAGAGGACGAGCAGAGTTAGGAGGTGAGAGGCTAATTGGAG GGCATTTCGGAATAAAGAGAGACTTGGGAGGCTTGGGTGAGGAGCTAAGAAAACTTGTGCTGGCATCCTAGGTTAGTGACAGCCCTGGGACTTCCAGGACACCCAGGACCTTTTGGCAGGCGAACTCA TCTCTATCGCCATCTAGTGGGCACTTCAAAGACTTGACCAACTTTGGCCACCTTAGGGCTTCCTATTGTCAAGTAGGTCTCACCCTGGGAGACAACCAACAACGAAAGCATGGCTCCATTACTGAGCT CCCAAGAGTGGTGTGTGGACCATACGTAAGGCTTGCCCCACACCTCGCCCTCAGGCCAAACCACTGGCCCCTTGTGAGTCTTGCCTTGACCCAAAAGGACCTGATGGAACCCAGCCCCTGGTGGCTCC TTAAAACTGAACCCTACCCACAATCTCCAAGGACAAAGGCTAGTTAGCTGAAGCGGGTATGGACAGGGATCCGTAAATCTGAGTCCAGAGAAGGTTCGTTCTGTGGGAAAGGCTTGTTCACAGGCAGT CCTCCCACTCAGGACACAGCCTGTCGGAAGAGACTGGATTACCGGCTAGCAGAACAGCACTGAGGTGTTTGAGGGCTGGGAGTGGTCCTAGAATCCCAAGGGAATGTGTTGGGTGTCAGGGACACCCA AGTTTGGGGGGCACTTGCCAGTAGAGACAAAGAGAAGGTCTATCCTTCCGATGAGGCTGAGAGATGGGGAGTGGTTAGTTAACACAGAGAAGGACCCAGGTCTGGAAAGGGTGCCAGGCCATCCACAG GAAAGAGAGGAGGTGAGACAATGGCCTGGTTTGGGACCAGGTGCTGAATGTTGTGTCTGCAGGGTATCTGAGAAGAGCCCCTCTAAGGCGGTTAGAAATTACAACCTAAAGGGACAGAGGGCAGGAAG ACCAAAGCAGTCCCTTTGGAAGGAACAGTGAGTGTCCGGGCAAGTCCCCAGGCACCCCATGGGGTGTGCTGGGCACAGTCTGGAGAGGAGACTGACTCAGCCCCTCCATCCTAGCTGCCACACAGGGT CTGTTTTAATGAGCAGTGGCCAGCTTCCCTACCCCCATGTGGGAACAAGAACAGCTCTTATCTCTCTGGGGGAAGGGGAAGGGGCGGGACCACAGCTGGCAGTCATTAAACACCCTGCTCTAGGCAGG GATGGCCAAGATATTAATAGCTTCGGGAGTCTATGGCCCCAAAGACTTGGCCTCCCAGGAAAAGGACAGAGCAACCGCAGCAGGCCAGAGGGATGCGTCAGGAGGCCATCTTGGCAATGCCCCAGCCT CCACACAAGGCAAATGGGATAACCAGAAAATAGAGAAGGAAAAGTCATTGTAGAGGCAGATGCTGAACCCAGCTTTCCAGAACCCCTGGTCGTGCCTCAGATATTCTATATCTTGTCAAAGATGGGGT CATTTGGCTGTGCCCTACCTGGAAACACAAAAAGAGTCGATCCAGTTAGCAGTCCTGATTCCGTCTTGACATATTGTTTATCCTGTATTTTTGCATTAATTTTGATATTTTAAAATACTGCATTAAAA TATTATTTACCTTGA
hide sequence
RefSeq Acc Id:
NP_035833 ⟸ NM_011703
- Peptide Label:
precursor
- UniProtKB:
Q9JI40 (UniProtKB/Swiss-Prot), Q9R1T8 (UniProtKB/Swiss-Prot), P97751 (UniProtKB/Swiss-Prot)
- Sequence:
MRPPSLPPARWLCVLAGALACALGPAGSRAASPHQECEYLQMIEKQRQQCLEEAQLENETTGCSKMWDNLTCWPTTPWGQVVVLDCPLIFQLFSPIHGYNISRNCTEEGWSQLEPGPYHIACGLNDRA SSMDEQQQTEFYDAVKTGYTIGYSLSLASLLVAMAILSLFRKLHCTRNYIHMHLFMSFILRATAVFIKDMALFNNGETDHCSEASVSCKAAVVFFQYCVMANFFWLLVEGLYLHTLLAVSFFSERKYF WGYILIGWGVPSVFIMIWTIVRIHFEDFGCWDTIINSSLWWIIKGPILISILVNFILFICIIRILVQKLRPPDIGKNDSSPYSRLAKSTLLLIPLFGVHYVMFAFFPDNFKAQVKMVFELVVGSFQGF VVAILYCFLNGEVQAELRRKWRRWHLQGVLGWSSKSQHPWGGSNGVSCSTQVSMLTRVSPSARRSSSFQAEVSLV
hide sequence
RefSeq Acc Id:
XP_006512131 ⟸ XM_006512068
- Peptide Label:
isoform X1
- Sequence:
MRPPSLPPARWLCVLAGALACALGPAGSRAASPHQECEYLQMIEKQRQQCLEEAQLENETTGCSKMWDNLTCWPTTPWGQVVVLDCPLIFQLFSPIHGYNISRNCTEEGWSQLEPGPYHIACGLNDRA SSMDEQQTEFYDAVKTGYTIGYSLSLASLLVAMAILSLFRKLHCTRNYIHMHLFMSFILRATAVFIKDMALFNNGETDHCSEASVSCKAAVVFFQYCVMANFFWLLVEGLYLHTLLAVSFFSERKYFW GYILIGWGVPSVFIMIWTIVRIHFEDFGCWDTIINSSLWWIIKGPILISILVNFILFICIIRILVQKLRPPDIGKNDSSPYSRLAKSTLLLIPLFGVHYVMFAFFPDNFKAQVKMVFELVVGSFQGFV VAILYCFLNGEVQAELRRKWRRWHLQGVLGWSSKSQHPWGGSNGVSCSTQVSMLTRVSPSARRSSSFQAEVSLV
hide sequence
Ensembl Acc Id:
ENSMUSP00000035115 ⟸ ENSMUST00000035115
RGD ID: 8671254
Promoter ID: EPDNEW_M13658
Type: initiation region
Name: Vipr1_1
Description: Mus musculus vasoactive intestinal peptide receptor 1 , mRNA.
SO ACC ID: SO:0000170
Source: EPDNEW (Eukaryotic Promoter Database, http://epd.vital-it.ch/ )
Experiment Methods: Single-end sequencing.
Position: Mouse Assembly Chr Position (strand) Source GRCm38 9 121,642,777 - 121,642,837 EPDNEW
Date
Current Symbol
Current Name
Previous Symbol
Previous Name
Description
Reference
Status
2016-04-05
Vipr1
vasoactive intestinal peptide receptor 1
AV071699
expressed sequence AV071699
Data merged from RGD:1613329
737654
PROVISIONAL